Executive Director, LST Strategies LLC (LinkedIn)
Gillian M. Fenton, Esq., CLP has been a member of the Licensing Executives Society (LES, USA & Canada) since 1992, and served as the society President in 2020-2021. Gillian’s contributions to LES and to the field of licensing were recognized with the society’s Frank Barnes Award in October 2022 and with listing in the IAM 300 in October 2023. She presently serves as U.S. Counsel to LESI and is a member of the LES USA & Canada Public Policy Committee and Course Chair for IP Licensing Basics.
Gillian is the founder and executive director of LST Strategies LLC, a solo law practice dedicated to life science transactions. For the prior 8 years, she was GSK Vaccines Special Counsel for Innovation and Government Collaborations. At GSK, she supported a wide variety of business development transactions, R&D collaborations and U.S. Government Contracts including agreements with NIH/NIAID, BARDA, DARPA, CARB-X and NIIMBL. Before joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields. Gillian also spent over ten years in private practice at law firms in Boston, MA and Washington, DC.
Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.
Admissions: MA, MD, DC. Registered U.S. Patent Attorney.
